Skip to main content
SpringerLink
Log in

Cellular origin of aldosteronomas

  • Review
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

In the 1950s, after years of suspicion and work by many investigators regarding a potent mineralocorticoid hormone from the adrenal cortex, aldosterone was at last isolated and chemically identified [40, 41]. Soon after, Jerome Conn was the first to report [11] the clinical correlate of excessive secretion of aldosterone from a benign adrenocortical tumor manifested by hypertension and hypokalemia with the increased urinary excretion of aldosterone. This tumor is often called as aldosteronoma, and the disorder produced by it has been called primary aldosteronism by Conn. In the vast majority of patients harboring such tumors, the hypertension is cured by the resection of the tumor [12, 51], although some suggest that the hypertension may recur in a proportion of apparently cured patients [3, 36]. Thus, primary aldosteronism represents one of a few potentially curable forms of hypertension. Since aldosterone is elaborated normally by the zona glomerulosa cells of the adrenal, it has been assumed that all aldosteronomas originate from the cells of the glomerulosa zone. A clonal origin of aldosteronomas has also been suggested [28]. Some earlier and recent developments, however, indicate that functionally there may be more than one type of aldosteronomas and that their cellular origins might be different.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACTH:

corticotrophin

CMO:

corticosterone methyl oxidases

References

  1. Bertholet JT (1980) Proliferative activity and cell migration in the adrenal cortex of the fetal and neonatal rats: an autoradiographic study. J Endocrinol 87:1–8

    Google Scholar 

  2. 2.Biglieri EG, Hane S, Slaton PE, Forsham PH (1963) In vivo and in vitro studies of adrenal secretion in vivo and in vitro in Cushing's syndrome and primary aldosteronism. J Clin Invest 42:516–524

    Google Scholar 

  3. Biglieri EG, Schambelan M, Slaton PE, Stockigt JR (1970) The intercurrent hypertension of primary aldosteronism. Circ Res 26 [Suppl 1]:I-195-I-202

    Google Scholar 

  4. Biglieri EG, Schambelan M, Brust N, Chang B, Hogan M (1974) Plasma aldosterone concentration. Further characterization of aldosterone-producing adenomas. Circ Res 34 [Suppl 1]:I-183-I-189

    Google Scholar 

  5. Biglieri EG, Irony I, Kater CE (1989) Identification and implications of new types of mineralocorticoid hypertension. J Steroid Biochem 32:199–204

    Google Scholar 

  6. Bloodworth JMB (1966) The adrenal. In: Sommers SC (ed) Pathology annual, vol l. Appleton-Century-Crofts, New York, pp 172–192

    Google Scholar 

  7. Brown C, Douglas J, Bravo E (1980) Angiotensin II receptor and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent non-tumorous tissue and normal human adrenal glomerulosa. J Clin Endocrinol Metab 51:718–723

    Google Scholar 

  8. Caplan RH, Virata RC (1974) Functional black adenoma of the adrenal cortex. A rare cause of primary aldosteronism. Am J Clin Pathol 62:97–103

    Google Scholar 

  9. Carey RM, Ayers CP, Vaughn ED, Peach MJ, Herf SM (1979) Activity of (des-aspartyl1)-angiotensin II in primary aldosteronism. J Clin Invest 63:718–726

    Google Scholar 

  10. Cater JB, Lever JD (1954) The zona intermedia of the adrenal cortex. A correlation-of-possible functional significance with development, morphology and histochemistry. J Anat 88:437–454

    Google Scholar 

  11. Conn JW (1955) Presidential address. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45:3–17

    Google Scholar 

  12. Conn JW (1966–1967) The evolution of primary aldosteronism: 1954–1967. Harvey Lect 62:257–291

    Google Scholar 

  13. Chu MD, Ulick S (1982) Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism. J Biol Chem 257:2218–2224

    Google Scholar 

  14. Ferriss JB, Beevers DG, Brown JJ, Davies DL, Fraser R, Lever AF, Mason P, Neville AM, Robertson JIS (1978) Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronism. Am Heart J 95:375–388

    Google Scholar 

  15. Fraser R, Beretta-Piccoli C, Brown JJ, Cumming AMM, Lever AF, Mason PA, Morton JJ, Robertson JIS (1981) Responses of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism. Hypertension 3 [Suppl 1]:I-87-I-92

    Google Scholar 

  16. Ganguly A (1990) Glucocorticoid-suppressible hyperaldosteronism: an update. Am J Med 88:321–324

    Google Scholar 

  17. Ganguly A, Donohue JP (1983) Primary aldosteronism: pathophysiology, diagnosis and treatment. J Urol 129:241–247

    Google Scholar 

  18. Ganguly A, Melada GA, Luetscher JA, Dowdy AJ (1973) Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 37:765–775

    Google Scholar 

  19. Ganguly A, Chavarri M, Luetscher JA, Dowdy A (1976) ACTH control of aldosterone secretion in aldosterone-producing adenoma (APA): further evidence. Program of the 58th annual meeting of the Endocrine Society, San Francisco, abstract no. 386

  20. Ganguly A, Luetscher JA, Weinberger MH (1983) Primary aldosteronism; effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration. Clin Exp Hypertens [A]5:133–154

    Google Scholar 

  21. Gomez-Sanchez CE, Montgomery M, Ganguly A, Holland OB, Gomez-Sanchez EP, Grim CE, Weinberger MH (1984) Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 59:1022–1024

    Google Scholar 

  22. Gomez-Sanchez CE, Gill JR, Ganguly A, Gordon RD (1988) Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone. J Clin Endocrinol Metab 67:444–448

    Google Scholar 

  23. Gordon RD, Hamlet SM, Tunny TJ, Klemm SA (1987) Aldosterone-producing adenoma responsive to angiotensin poses problems in diagnosis. Clin Exp Pharmacol Physiol 14:175–179

    Google Scholar 

  24. Greep RO, Deane HW (1949) The cytology and cytochemistry of the adrenal cortex. Ann NY Acad Sci 50:596–615

    Google Scholar 

  25. Guthrie GP (1981) Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism. J Lab Clin Med 98:364–373

    Google Scholar 

  26. Hamlet SM, Gordon RD, Gomez-Sanchez CE, Tunny TJ, Klemm SA (1988) Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism are ACTH-dependent. Clin Exp Pharmacol Physiol 15:317–322

    Google Scholar 

  27. Horton R (1969) Stimulation and suppression in plasma of normal man and in primary aldosteronism. J Clin Invest 48:1231–1236

    Google Scholar 

  28. Jackson CE, Cerny JC, Block MA, Falkow AJ (1982) Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid “adenomas”. Surgery 92:875–879

    Google Scholar 

  29. Kawamoto T, Mitsuchi Y, Ohnishi T, Ichikawa Y, Yokoyama Y, Sumimoto H, Toda K, Miyahara K, Kuribayashi I, Nakao K, Hosoda K, Yamamoto Y, Imura H, Shizuta Y (1990) Cloning and expression of a cDNA for human cytochrome P-450 aldo as related to primary aldosteronism. Biochem Biophys Res Commun 173:309–316

    Google Scholar 

  30. Kay S (1976) Hyperplasia and neoplasia of the adrenal gland. In: Sommers SC (ed) Pathology annual, vol 11. Appleton-Century-Crofts, New York, pp 103–139

    Google Scholar 

  31. Kem DC, Weinberger MH, Gomez-Sanchez CE, Kramer NJ, Lerman R, Furuyama S, Nugent CA (1973) Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 52:2272–2277

    Google Scholar 

  32. Kern DC, Weinberger MH, Higgins JH, Kramer NJ, Gomez-Sanchez C, Holland OB (1978) Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46:552–560

    Google Scholar 

  33. Komiya I, Koizumi Y, Kobayashi Y, Kotani M, Yamada T, Maruyama Y (1979) Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma. Am J Med 67:516–518

    Google Scholar 

  34. Long JA (1975) Zonation of the mammalian adrenal cortex. In: Greep RO, Astwood EB (eds) Handbook of physiology, vol VI. Adrenal gland. American Physiological Society, Washington, pp 13–24

    Google Scholar 

  35. Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C (1981) Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity, and aldosterone in primary aldosteronism. Clin Sci 61:289s-293s

    Google Scholar 

  36. Melby JC (1984) Primary aldosteronism. Kidney Int 26:769–778

    Google Scholar 

  37. Neville A, O'Hare MJ (1985) Histopathology of the human adrenal cortex. Clin Endocrinol Metab 14:791–820

    Google Scholar 

  38. Nomura K, Naruse M, Naruse K, Demura H, Shizume K (1984) In vivo evidence of cortisol secretion by aldosterone-producing adenoma. Acta Endocrinol (Copenh) 106:516–520

    Google Scholar 

  39. Priestley JT, Ferris DO, ReMine WH, Woolner LB (1968) Primary aldosteronism: surgical management and pathological findings. Mayo Clinic Proc 48:761–775

    Google Scholar 

  40. Simpson SA, Tait JF, Bush IE (1952) Secretion of a salt-retaining hormone by the mammalian adrenal cortex. Lancet 11:226–227

    Google Scholar 

  41. Simpson SA, Tait JF, Wettstein A, Neher R, Schindler JVEO, Reichstein T (1954) Konstitution des aldosterons, des neuen mineralocorticoids. Experimentia 10:132–133

    Google Scholar 

  42. Slaton PE, Schambelan M, Biglieri EG (1969) Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab 29:239–250

    Google Scholar 

  43. Spark RF, Dale SL, Kahn PC, Melby JC (1969) Activation of aldosterone secretion in primary aldosteronism. J Clin Invest 48:96–104

    Google Scholar 

  44. Symington T (1969) Functional pathology of the adrenal gland. Livingstone, Edinburgh, pp 3–216

    Google Scholar 

  45. Tannenbaum M (1973) Ultrastructural pathology of the adrenal cortex. In: Sommers SC (ed) Pathology annual, vol 8. Appleton-Century-Crofts, New York, pp 109–156

    Google Scholar 

  46. Ulick S (1976) Diagnosis and nomenclature of the disorders of terminal portion of the aldosterone biosynthetic pathway. J Clin Endocrinol Metab 43:92–96

    Google Scholar 

  47. Ulick S (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens [A]4 (9&10):1771–1777

    Google Scholar 

  48. Ulick S, Chu MD, Land M (1983) Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J Biol Chem 258:5498–5502

    Google Scholar 

  49. Ulick S, Chan CK, Gill JR, Gutkin M, Letcher L, Mantero F, New MI (1990) Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 71:1151–1157

    Google Scholar 

  50. Vetter H, Berger M, Armbruster H, Siegenthaler W, Werning C, Vetter W (1974) Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol. Clin Endocrinol (Oxf) 3:41–48

    Google Scholar 

  51. Weinberger MH, Grim CE, Hollifield JW, Ganguly A, Kramer NJ, Yune HY, Wellman H (1979) Primary aldosteronism. Diagnosis, localization, and treatment. Ann Intern Med 90:386–395

    Google Scholar 

  52. Wenting GJ, Veld AJ Man In't, Derks FH, Brummelan PV, Schalekamp MADH (1978) ACTH-dependent adrenocortical adenoma. A variant of primary aldosteronism. J Clin Endocrinol Metab 46:326–335

    Google Scholar 

  53. Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ (1981) The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195–198

    Google Scholar 

  54. Witzgall H, Muller DA, Weber PC (1983) Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic aldosteronism. Klin Wochenschr 61:35–42

    Google Scholar 

  55. Yamagibashi K, Haniu M, Shively JE, Shen WH, Hall PF (1986) The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for l1β/18-hydroxylation and aldehyde synthesis. J Biol Chem 261:3556–3562

    Google Scholar 

  56. Zajicek G, Ariel I, Arber N (1985) The streaming adrenal cortex: direct evidence of centripetal migration of adrenocytes by estimation of cell turnover rate. J Endocrinol 111:477–482

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Service, James A. Haley Veterans Hospital and the University of South Florida College of Medicine, 13000 B.B. Downs Boulevard, 33617, Tampa, FL, USA

    A. Ganguly

Authors
  1. A. Ganguly
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ganguly, A. Cellular origin of aldosteronomas. Clin Investig 70, 392–395 (1992). https://doi.org/10.1007/BF00235519

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00235519

Key words

Search

Navigation